Restoration of Myocardial Healing by Extracellular Matrix Remodeling
通过细胞外基质重塑恢复心肌愈合
基本信息
- 批准号:9324066
- 负责人:
- 金额:$ 18.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAdultAgingApoptosisApoptoticAppearanceBindingBiologyCardiacCardiac MyocytesCatecholaminesCell CommunicationCell SurvivalCell physiologyCell surfaceCellsCicatrixCollaborationsCollagenDataDependovirusDevelopmentEngineeringEngraftmentEnvironmentExtracellular MatrixExtracellular Matrix ProteinsFOS geneFibronectin ReceptorsFibronectinsFocal Adhesion Kinase 1Functional disorderGoalsHealthcare SystemsHeartHeart DiseasesHeart HypertrophyHeart failureHypertrophyImmediate-Early GenesImmunoblot AnalysisImmunohistochemistryIn VitroInfarctionInhibition of ApoptosisInjuryInnovative TherapyInstructionIntegrinsIntravenousJUN geneMaintenanceMalignant NeoplasmsMediatingMitogen-Activated Protein KinasesModelingModificationMolecularMyocardialMyocardial InfarctionMyocardiumNatural regenerationOxidative StressParticipantPathologicPathway interactionsPerformancePhosphorylationPhosphotransferasesPublic HealthReceptor ActivationRecruitment ActivityRegenerative MedicineRegimenRegulationResearchResistanceReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSmall Interfering RNAStarvationStem cellsTechniquesTherapeuticTherapeutic InterventionTissuesTranslatingUnited Statesbiological adaptation to stressc-myc Genescardiac repaircardiogenesiscell growthclinical applicationexpectationextracellulargene inductionhealingimprovedin vivoinnovationknock-downmortalitymouse modelnoveloverexpressionprogramsproto-oncogene protein pimproto-oncogene protein pim-1receptor expressionrepairedresponseresponse to injuryrestorationspatiotemporalsurvivinvector
项目摘要
Discovery of cardiac progenitor cells (CPCs) in the adult tieart hias led to tieightened expectations for novel
treatments of cardiac disease. However, adoptive transfer of CPCs results only in transient improvement of
cardiac performance as most donated cells fail to persist in the hostile milieu of the ischemic scar. Whereas
approaches focus upon enhancing capabilities of stem cells, engineering of the damaged myocardium is a
valid alternative strategy to enhance myocardial repair and regeneration. Extracellular matrix (ECM) proteins
are pivotal components of the myocardial environment important in maintenance of cellular function. The
overall goal of this proposal is to improve the survival, proliferation, recruitment, and persistence of CPC in
the damaged myocardium by modification of fibronectin (Fn) expression, an ECM protein which correlates
highly with spatio-temporal appearance of CPCs in the heart. Our preliminary data delineate a Fn-a5pi-FAK-
Pim-1 signaling cascade regulating CPC growth and survival. Relevance of Fn, aSpi, FAK and Pim-1 in
cardiomyocyte biology are well accepted, however, nothing is known about this pathway in CPCs. The short
term goal is to understand the significance of the Fn-a5pi-FAK-Pim-1 pathway in CPCs under pathological
conditions and extrapolate an innovative therapeutic approach to engineer the extracellular environment of
the damaged myocardium to enhance regeneration and repair. Translational potential will be explored using
an adeno-associated virus type 9 (AAV9) vector expressing a f unctional collagen-tethered Fn fragment to
enhance CPC survival, proliferation, recruitment, and engraftment. Our specific aims are: 1) The Fn-a5(31-
FAK-Pim-1 signaling axis is triggered following cardiomyopathic injury in vivo, 2) a5(31-integrin receptor
activation by Fn induces i mmediate ea riy s tress r esponses, s urvival, and pr oliferation v ia FAK-Pim-1
signaling in CPCs, 3) Robust and persistent CPC-dependent regeneration is mediated by overexpression of
a collagen binding Fn fragment delivered by cardiotropic AAV9 vector. Significance is to define beneficial
aspects of endogenous repair to injury response. The long term goal is to translate the Fn fragment
expressing AAV9 regimen into clinical application to establish innovative therapy for regenerative medicine.
RELEVANCE (See instructions):
Heart disease, especially heart failure is a major public health issue in the United States with a considerable
burden for the health care system. Despite recent progress in understanding the pathophysiology, heart
failure still carries a 5-year mortality that rivals most cancers. This proposal focuses upon understanding how
the environment of the damaged heart can impact upon repair and regeneration on a cellular and molecular
level.
在成体动脉瘤中发现心脏祖细胞(CPC),引发了对新型心脏祖细胞的期望。
心脏病的治疗。然而,CPC 的过继转移只能暂时改善
由于大多数捐赠的细胞无法在缺血性疤痕的恶劣环境中持续存在,因此心脏功能受到影响。然而
方法侧重于增强干细胞的能力,受损心肌的工程是一种
增强心肌修复和再生的有效替代策略。细胞外基质 (ECM) 蛋白
是心肌环境的关键组成部分,对于维持细胞功能非常重要。这
该提案的总体目标是改善 CPC 的生存、扩散、招募和持久性
通过纤连蛋白 (Fn) 表达的修饰来修复受损的心肌,纤连蛋白 (Fn) 是一种 ECM 蛋白,与
与心脏中 CPC 的时空表现高度相关。我们的初步数据描绘了 Fn-a5pi-FAK-
Pim-1 信号级联调节 CPC 生长和存活。 Fn、aSpi、FAK 和 Pim-1 的相关性
心肌细胞生物学已被广泛接受,然而,人们对 CPC 中的这一通路一无所知。短的
术语目标是了解 Fn-a5pi-FAK-Pim-1 通路在病理条件下 CPC 中的重要性
条件并推断出一种创新的治疗方法来设计细胞外环境
增强受损心肌的再生和修复。将利用以下方式探索转化潜力
腺相关病毒 9 型 (AAV9) 载体,表达功能性胶原蛋白束缚的 Fn 片段
增强 CPC 的存活、增殖、招募和植入。我们的具体目标是: 1) Fn-a5(31-
FAK-Pim-1 信号轴在体内心肌病损伤后被触发,2) a5(31-整合素受体)
Fn 激活可通过 FAK-Pim-1 诱导立即应激反应、存活和增殖
CPC 中的信号传导,3) 稳健且持久的 CPC 依赖性再生是通过过度表达介导的
由心肌 AAV9 载体传递的胶原蛋白结合 Fn 片段。意义在于定义有益的
损伤反应的内源性修复方面。长期目标是翻译 Fn 片段
将AAV9方案表达到临床应用,建立再生医学的创新疗法。
相关性(参见说明):
心脏病,特别是心力衰竭是美国的一个主要公共卫生问题,在美国有相当大的影响。
医疗保健系统的负担。尽管最近在了解病理生理学方面取得了进展,但心脏
失败的五年死亡率仍与大多数癌症相当。该提案的重点是了解如何
受损心脏的环境会影响细胞和分子的修复和再生
等级。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK ALAN SUSSMAN其他文献
MARK ALAN SUSSMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK ALAN SUSSMAN', 18)}}的其他基金
Next Generation Regenerative Therapy with Pim-1 Enhanced Cardiac Progenitor Cells
使用 Pim-1 增强型心脏祖细胞的下一代再生疗法
- 批准号:
9352458 - 财政年份:2017
- 资助金额:
$ 18.21万 - 项目类别:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
利用 CardioClusters 和 CardioChimeras 增强心肌修复
- 批准号:
8675146 - 财政年份:2014
- 资助金额:
$ 18.21万 - 项目类别:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
利用 CardioClusters 和 CardioChimeras 增强心肌修复
- 批准号:
9266810 - 财政年份:2014
- 资助金额:
$ 18.21万 - 项目类别:
Enhanced Myocardial Repair with CardioClusters and CardioChimeras
利用 CardioClusters 和 CardioChimeras 增强心肌修复
- 批准号:
9041013 - 财政年份:2014
- 资助金额:
$ 18.21万 - 项目类别:
Beta-adrenergic signaling: double edged sword of myocardial repair
β-肾上腺素能信号传导:心肌修复的双刃剑
- 批准号:
8431986 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
Beta-adrenergic signaling: double edged sword of myocardial repair
β-肾上腺素能信号传导:心肌修复的双刃剑
- 批准号:
8790766 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
Cardioprotection by optimizing mTOR activity
通过优化 mTOR 活性来保护心脏
- 批准号:
8446101 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
Cardioprotection by optimizing mTOR activity
通过优化 mTOR 活性来保护心脏
- 批准号:
8792404 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
Beta-adrenergic signaling: double edged sword of myocardial repair
β-肾上腺素能信号传导:心肌修复的双刃剑
- 批准号:
8996702 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
Cardioprotection by optimizing mTOR activity
通过优化 mTOR 活性来保护心脏
- 批准号:
8620713 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 18.21万 - 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
- 批准号:
10660046 - 财政年份:2023
- 资助金额:
$ 18.21万 - 项目类别:
Understanding Longer-Living Older Adult Research: The Summer Program on Aging
了解长寿老年人研究:老龄化夏季项目
- 批准号:
476343 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Role of sensory experience in the regulation of plasticity in the developing, adult and aging brain
感官体验在发育、成人和衰老大脑可塑性调节中的作用
- 批准号:
RGPIN-2019-04761 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Discovery Grants Program - Individual
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10365348 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10700796 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10651861 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Investigating the interface of epigenetics and metabolism underlying memory formation in the adult, aging, and AD brain
研究成人、衰老和 AD 大脑中记忆形成的表观遗传学和代谢界面
- 批准号:
10420533 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10846200 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
THE DEVELOPMENT OF MECHANISM-BASED ADULT STEM CELL TREATMENTS TO COMBAT AGING PATHOLOGIES
开发基于机制的成人干细胞疗法来对抗衰老病理学
- 批准号:
10721544 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别: